Lilly Pharma - Search News

Lilly Endowment sells $31.18 million in Eli Lilly stock

INDIANAPOLIS—Lilly Endowment Inc., a major shareholder in Eli Lilly & Co. (NYSE:LLY), has recently sold a significant portion of its holdings in the pharmaceutical giant. According to a recent SEC filing,

MarketWatch · 21h

Eli Lilly & Co. stock underperforms Friday when compared to competitors

Shares of Eli Lilly & Co. LLY slid 3.00% to $844.27 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 0.01% to 6,114.63 and Dow Jones Industrial Average DJIA falling 0.

The Motley Fool · 5h

Think Eli Lilly's Stock Is Expensive? Here's Why Selling It Now Could Be a Huge Mistake

The price a stock trades at can drastically impact your overall returns. A metric such as the price-to-earnings (P/E) ratio can be helpful in enabling you to easily gauge how expensive or cheap a stock is.

FiercePharma3d

Lilly encourages women to 'take health into their own hands' with new breast cancer awareness ad

So far in 2025, the year’s biggest cultural events have served as launchpads for several of the industry's latest cancer ...

BioSpace4d

Lilly Signs Back-to-Back Deals in MASH, Cancer

Eli Lilly inked two collaborations on Monday, one focused on cardiometabolic diseases with South Korea’s OliX Pharmaceuticals ...

MM&M3d

How new direct-to-consumer platforms are changing pharma’s relationships with patients

New DTC platforms like LillyDirect and PfizerForAll are triggering a paradigm shift in how pharma companies connect with patients.

FierceBiotech5d

Eli Lilly inks duo of deals, teaming with AdvanCell, OliX to push deeper into radiopharma, MASH

Eli Lilly has begun the week with a bang. Early Monday morning, AdvanCell and OliX Pharmaceuticals put out news that the Big ...

BioSpace3d

Lilly, Novo Skew Overall Pharma Trends With Colossal GLP-1 Sales Growth

From revenue to R&D investment, Novo and Lilly and their mega-blockbuster weight loss drugs Zepbound and Wegovy have moved ...

Lilly Sells $6.5 Billion of Bonds for Cancer Drug Purchase

Eli Lilly & Co. tapped the US investment-grade bond market on Monday to help finance its roughly $2.5 billion purchase of a ...

FierceBiotech8d

Eli Lilly's next R&D focus: Testing incretin meds in neuro, immunology fields

Eli Lilly has invested heavily into obesity, dominating the landscape—alongside semaglutide maker Novo Nordisk—with its ...

1don MSN

West Pharma’s stock tanks 33% to lead S&P 500 decliners as guidance misses by a wide margin

West Pharmaceutical Services Inc.’s stock tumbled 33% Thursday, to lead S&P 500 decliners, after the manufacturer of injectable-pharmaceutical packaging and delivery systems offered guidance for 2025 ...

MM&M5d

Inside Eli Lilly’s bold breast cancer awareness ad debut at the Grammys

Eli Lilly’s latest TV ad, unveiled during the Grammys on Sunday night, highlights the importance of early diagnosis for ...

FiercePharma1d

Fierce Pharma Asia—Astellas' investment focus; Mitsubishi Tanabe's buyout; Leqembi's 'expansion phase'

Astellas is shifting its investment focus toward more established modalities and later-stage opportunities, its chief ...

STAT1d

As Trump pauses enforcement of an anti-bribery law, will pharma engage in bad behavior?

The Trump administration's decision to pause enforcement of an anti-bribery law raised the specter that drugmakers could ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results